AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 177 filers reported holding AXSOME THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $682,196 | -18.9% | 9,761 | -16.6% | 0.00% | -50.0% |
| Q2 2023 | $841,265 | +54.6% | 11,707 | +32.7% | 0.00% | +100.0% |
| Q1 2023 | $544,326 | -18.7% | 8,825 | +1.7% | 0.00% | -50.0% |
| Q4 2022 | $669,257 | +27.2% | 8,677 | -26.4% | 0.00% | +100.0% |
| Q3 2022 | $526,000 | +141.3% | 11,785 | +106.9% | 0.00% | – |
| Q2 2022 | $218,000 | -60.5% | 5,696 | -15.9% | 0.00% | -100.0% |
| Q4 2020 | $552,000 | -44.7% | 6,774 | -51.6% | 0.00% | -50.0% |
| Q3 2020 | $998,000 | -31.7% | 14,005 | -21.1% | 0.00% | 0.0% |
| Q2 2020 | $1,461,000 | +16.1% | 17,755 | -17.0% | 0.00% | 0.0% |
| Q1 2020 | $1,258,000 | -56.3% | 21,385 | -23.3% | 0.00% | -33.3% |
| Q4 2019 | $2,880,000 | +627.3% | 27,865 | +42.3% | 0.00% | – |
| Q3 2019 | $396,000 | – | 19,588 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 758,794 | $53,032,113 | 65.14% |
| Fairmount Funds Management LLC | 2,341,238 | $163,629,124 | 19.69% |
| Ally Bridge Group (NY) LLC | 110,600 | $7,729,834 | 9.07% |
| RTW INVESTMENTS, LP | 4,489,596 | $313,777,864 | 6.62% |
| SVB FINANCIAL GROUP | 33,849 | $2,365,707 | 4.45% |
| BVF INC/IL | 2,131,100 | $148,942,579 | 4.02% |
| Altium Capital Management LP | 92,000 | $6,429,880 | 3.35% |
| Tri Locum Partners LP | 142,510 | $9,960,024 | 3.18% |
| TANG CAPITAL MANAGEMENT LLC | 320,000 | $22,364,800 | 3.16% |
| Deep Track Capital, LP | 1,140,745 | $79,726,668 | 3.08% |